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Abstract:  Acne vulgaris may be improved by dietary factors that increase insulin 
sensitivity. We hypothesized that a low-glycemic index diet would improve facial acne 
severity and insulin sensitivity. Fifty-eight adolescent males (mean age ± standard 
deviation 16.5 ± 1.0 y and body mass index 23.1 ± 3.5 kg/m
2) were alternately allocated to 
high or low glycemic index diets. Severity of inflammatory lesions on the face, insulin 
sensitivity (homeostasis modeling assessment of insulin resistance), androgens and   
insulin-like growth factor-1 and its binding proteins were assessed at baseline and at eight 
weeks, a period corresponding to the school term. Forty-three subjects (n = 23 low 
glycemic index and n = 20 high glycemic index) completed the study. Diets differed 
significantly in glycemic index (mean ± standard error of the mean, low glycemic index 
51 ± 1 vs. high glycemic index 61 ± 2, p = 0.0002), but not in macronutrient distribution or 
fiber content. Facial acne improved on both diets (low glycemic index 
−26 ± 6%, p = 0.0004  and  high  glycemic  index  −16 ± 7%, p = 0.01), but differences 
between diets did not reach significance. Change in insulin sensitivity was not different 
between diets (low glycemic index 0.2 ± 0.1 and high glycemic index 0.1 ± 0.1, p = 0.60) 
and did not correlate with change in acne severity (Pearson correlation r = −0.196, 




p = 0.244). Longer time frames, greater reductions in glycemic load or/and weight loss 
may be necessary to detect improvements in acne among adolescent boys. 
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1. Introduction  
Acne vulgaris (acne) is a prevalent skin disorder with substantial physical and psychological 
morbidity. Although dietary factors have long been considered unimportant, insulin resistance (IR) and 
dietary carbohydrates have recently been implicated in the etiology of acne [1,2]. The glycemic 
index (GI) of meals has been directly correlated to insulin response [3] and low GI diets have been 
shown to decrease IR [4]. High insulin concentrations in the fasting and/or postprandial state may 
exacerbate acne by increasing the proliferation of basal keratinocytes. Insulin also stimulates the 
synthesis of androgens leading to high sebum production, a recognized correlate of acne severity [5]. 
IR could also increase inflammatory responses within and adjacent to the comedo [6]. 
Postprandial insulin responses may be of particular relevance during puberty and adolescence when 
whole-body IR naturally increases [7]. Insulin sensitivity and sex-hormone-binding globulin (SHBG) 
are directly correlated, such that falls in insulin sensitivity increase the free androgen   
index  (FAI) [8,9]. Similarly, compensatory hyperinsulinemia is associated with reductions in   
insulin-like growth factor binding protein-1 (IGFBP-1), corresponding to higher cellular 
concentrations of free insulin-like growth factor-1 (IGF-1) [9]. Indeed, the highest incidence of acne 
occurs when IGF-1 levels peak [10] and adult women with acne have high levels of IGF-1 [11]. 
Interventions that reduce fasting and postprandial insulinemia and IGF-1 concentrations would 
therefore be expected to decrease sebum production and keratinocyte proliferation [12].  
In the first study of its kind, Smith et al. demonstrated that reductions in carbohydrate intake with 
particular emphasis on low glycemic index (GI) carbohydrate foods, improved cutaneous and 
hormonal markers of acne severity in young adult males [2]. Several confounders, however, 
complicated the interpretation of the study because the treatment group lost more weight, and had 
higher protein and fiber intake than the control group—factors which the authors discussed. Since 
weight loss as well as higher protein and fiber intake have all been linked to improved insulin 
sensitivity, it is not clear whether dietary GI played an important role in the improvement of acne. 
In the present study, we hypothesized that in the context of weight maintenance and identical 
macronutrient and fiber intake, the replacement of high GI carbohydrates with low GI carbohydrates 
would improve acne severity by lowering postprandial insulin concentrations and/or decreasing IR. We 
studied adolescent males attending boarding school so that food intakes could be more easily controlled.  
2. Methods 
2.1. Subjects 
Healthy adolescent males with acne were recruited at three secondary boarding schools in Sydney, 




over the past three months and parental/guardian consent. Exclusion criteria were previous use of 
isotretinoin, antibiotics in the past month, excessive alcohol intake, illicit drug use, smoking, physical 
or mental illness, food allergy or intolerance, vegetarianism, previous surgery on the gastrointestinal 
system, black skin (due to difficulty in visualizing lesions), or final school examinations in the coming 
months. This study was conducted according to the guidelines laid down in the Declaration of Helsinki 
and all procedures involving human subjects were approved by the Sydney University Human 
Research Ethics Committee. Written informed consent was obtained from all subjects and their 
parents/guardians. The trial is registered with the Australian New Zealand Clinical Trials Registry 
(ANZCTR) ACTRN12610000261011 and Unique Trial Number (UTN) U1111-1114-5335. 
2.2. Study protocol 
The study was of parallel design and volunteers were assigned alternately to the high or low GI diet 
in order of recruitment. They were informed that the study was designed to determine the effect of the 
GI of carbohydrates on acne. Subjects were instructed to maintain their current washing regime. At 
baseline, height and weight were measured in light clothing and without shoes. Weight was recorded 
weekly and food diaries were completed on Saturday and Sunday of every week. Dietary records were 
analyzed using Food Works software package 3.02 (Xyris Software, Highgate Hill, Australia), based 
on the Australian food composition tables. Average weighted GIs were calculated from the diaries 
using the GI values of individual food components [13] and their relative contribution to total 
carbohydrate in the meal. At baseline and at eight weeks, severity of facial acne was assessed by a 
dermatologist. Blood (6 mL) was obtained via a cannula inserted into the antecubital vein of the lower 
arm and transferred into EDTA-coated Vacutainer tubes before being stored at −20 °C. 
2.3. Diets 
In one-to-one weekly counseling sessions, subjects were given detailed instruction on how to follow 
an ad libitum high or a low GI diet, with written material to supplement these sessions. Diet advice 
differed only in the type of carbohydrate to be eaten at meals provided in the school dining hall/at 
home. School menus were assessed to ensure high and low GI options were available at every meal, 
and instructions were sent to parents if boarders returned home at weekends. Snack foods were 
provided in hampers on a weekly basis. Low GI foods included verified low GI brands of muesli, a 
sports drink and a processed fruit snack, and lasagne [13]. High GI foods included verified high GI 
brands of wheat breakfast biscuits, a sports drink and a processed fruit snack, and baked potato with 
chili con carne [13]. 
2.4. Assessment of acne severity 
A dermatologist (SL or JC) who was blind to diet allocation assessed facial acne severity by 
examining the number and degree of inflammation of inflammatory lesions (papules, pustules and 
nodules, not comedones or scars) on the face under ceiling fluorescent lighting or daylight. Acne was 
graded on a scale from 0 to 3 (0: no acne, 1: mild, 2: moderate and 3: severe). Photographs were taken 




dermatologist (SL), a second dermatologist (JC) completed some of the final assessments. The first 
dermatologist later graded photographs from these assessments and an average was taken from the two 
grades of facial acne severity. 
2.5. Blood analysis 
Vacutainer tubes (6 mL) were centrifuged (Eppendorf 5702R refrigerated centrifuge) at 3000 rpm 
(112 RCF) for 5 min at 4 °C, plasma aliquoted and stored at −80 °C until assay. Glucose was measured 
in-house using a glucose hexokinase assay (Roche Diagnostics Corporation, Indianapolis, IN). Insulin 
was measured in-house in duplicate by competitive RIA (Coat-a-Count, Diagnostic Products, 
Los Angeles, CA, intra-assay CV 4.6%). Homeostasis modeling assessment of IR (HOMA-IR) was 
calculated as follows: glucose mmol/L × (insulin pmol/L/6)/22.5 [14]. Testosterone (total), SHBG, 
dihydroepiandrosterone-sulfate (DHEA-S) and total IGF-1 were measured externally at the 
Biochemistry Department of the Royal Prince Alfred Hospital, Sydney: testosterone and DHEA-S by 
competitive chemiluminescence EIA (Immulite 2000, Siemens Medical Solutions Diagnostic, 
Los  Angeles, CA), SHBG by two-site chemiluminescence EIA (Immunite 2000, Siemens Medical 
Solutions Diagnostic, Los Angeles, CA) and IGF-1 by in-house RIA. IGFBP-1 and -3 were measured 
externally at the Molecular Medicine Department of the Royal North Shore Hospital by RIA 
(Baxter et al. [15] for IGFBP-1 and Baxter and Martin [16] for IGFBP-3). The FAI was calculated as: 
(testosterone nmol/L × 100)/SHBG nmol/L.  
2.6. Statistical analysis 
Power calculations based on previous studies [17] showed at least 15 subjects per dietary 
intervention would provide >90% power to detect an effect size of ~50% in acne severity between the 
low and the high GI diets (p < 0.05). In the final analysis, a general linear model for change in acne 
severity was used, in which dermatologist and diet were fixed factors and baseline values were treated 
as a covariate (this allowed for the change in dermatologist as well as the change in the method of 
facial acne assessment, i.e., photo vs. in-person). Changes over time within diets were compared using 
paired Student’s t-tests. Differences between the degree of change on each diet were compared using 
independent samples Student’s t-tests. Pearson’s correlations between acne severity and biochemical 
parameters were obtained. Statistical calculations were carried out using SPSS 14 for Windows 
(SPSS Inc., Chicago, IL). Results are expressed as mean ± SEM unless otherwise stated. Differences 
are considered significant if p < 0.05 and highly significant if p < 0.01. 
3. Results and Discussion 
A total of 58 subjects met the inclusion criteria, of which 29 were assigned to the high GI and 29 to 
the low GI diet (per protocol results). Twelve subjects discontinued because they were unwilling to 
adhere to the diet (four on the low GI diet and eight on the high GI diet) and three subjects were 
omitted from data analysis due to missing acne gradings (dermatologist appointments were cancelled 
due to illness). Forty-three subjects completed the study (n = 23 low GI and n = 20 high GI). The 
mean ± SD age (16.6 ± 1.1 y) and BMI (23.6 ± 3.8 kg/m




different to the subjects who discontinued (age 16.4 ± 0.7 y and BMI 21.9 ± 2.3 kg/m
2, p = 0.72 and 
p = 0.12, respectively). On the whole, there were no significant differences in subject characteristics, 
baseline acne severity or blood biochemistry between the two diet groups (Table 1). However, at 
baseline, DHEA-S was higher in those allocated to the low GI diet (p = 0.04). As determined by the 
study protocol, diets differed significantly in GI (low GI diet 51 ± 1 vs. high GI diet 61 ± 2, 
p = 0.0002), but not energy, protein, total fat, carbohydrate, fiber, zinc or calcium content (Table 2). 
Diets also differed significantly in saturated fat (low GI diet 13 ± 0% vs. high GI diet 15 ± 1%, p = 0.01). 
Changes in weight were minor and not different within or between diet groups (low GI −0.3 ± 0.4 kg 
vs. high GI 1.1 ± 0.6 kg, p = 0.053). 
Table 1. Baseline subject characteristics, acne severity and blood variables. 
  Low GI, n = 23  High GI, n = 20  P 
  Mean ± SEM  Mean ± SEM   
Age (y)  16.6 ± 0.2  16.5 ± 0.3  0.92 
BMI (kg/m
2)  24.0 ± 1.0 
a  23.1 ± 0.6 
b 0.45 
Weight (kg)  76.0 ± 3.3  75.4 ± 1.8  0.87 
Facial acne score/3  2.1 ± 0.1  1.9 ± 0.2  0.30 
Glucose (mmol/L)  4.7 ± 0.1 
c  4.8 ± 0.1  0.54 
Insulin (pmol/L)  22.7 ± 4.1 
c  22.9 ± 2.3  0.98 
HOMA-IR  0.7 ± 0.1 
c  0.8 ± 0.1  0.51 
Testosterone (nmol/L)  34.3 ± 1.8 
c  32.4 ± 1.6  0.43 
SHBG (nmol/L)  23.7 ± 2.4 
c  26.4 ± 2.1   0.59 
FAI (nmol/L)  177.7 ± 20.6 
c  142.6 ± 12.7  0.16 
DHEA-S (µmol/L)  5.9 ± 0.6 
c  4.5 ± 0.4  0.04 
IGF-1 (nmol/L)  56.6 ± 4.7 
c  57.8 ± 3.6  0.84 
IGFBP-1 (ng/mL)  33.4 ± 6.0 
c  30.8 ± 3.1  0.71 
IGFBP-3 (µg/mL)  6.2 ± 0.3 
c  6.3 ± 0.4  0.84 
DHEA-S: dehydroepiandrosterone-sulfate; FAI: free androgen index; GI: glycemic index; 
HOMA-IR: homeostasis modeling assessment of insulin resistance; IGF-1: insulin-like growth 
factor-1; IGFBP-1 and -3: insulin like growth factor binding proteins -1 and -3; P: independent 
samples t-test; SHBG: sex hormone binding globulin; 
a: n = 22; 
b: n = 19; 
c: n = 20; Three subjects 
on the low GI diet refused blood collection. 
Table 2. Daily nutrient intakes calculated from the food diaries that were filled out every 
weekend during the intervention period for eight weeks. 
  Low GI, n = 20 
a  High GI, n = 17 
b p 
  Mean ± SEM  Mean ± SEM   
E (kJ)  8164 ± 584  9417 ± 571  0.14 
Protein (%E)  21 ± 1  19 ± 1  0.06 
Fat (%E)  34 ± 1  36 ± 1  0.11 
Monounsaturated fat (%E)  13 ± 0  13 ± 0  0.46 
Polyunsaturated fat (%E)  4 ± 0  4 ± 0  0.85 
Saturated fat (%E)  13 ± 0  15 ± 1  0.01 
Carbohydrate (%E)  39 ± 2  42 ± 2  0.25 




Table 2. Cont. 
Fiber (g)  16 ± 2  15 ± 1  0.50 
Zinc (mg)  13 ± 1  14 ± 1  0.44 
Calcium (mg)  640 ± 67  796 ± 83  0.15 
Glycemic index  51 ± 1  61 ± 2  0.0002 
Glycemic load  102 ± 9  157 ± 18  0.01 
E: energy; 
a: 3 subjects from the low GI diet lost their food diaries; 
b: 3 subjects from the high GI 
diet lost their food diaries. 
Facial acne improved on both diets (low GI −26 ± 6%, p = 0.0004 and high GI −16 ± 7%, p = 0.01), 
but differences between diets did not reach significance (Figure 1, Table 3). Similarly, there were no 
significant differences within or between diets for most biochemical parameters. However, IGFBP-1 
declined significantly on the low GI diet versus the high GI diet (low GI −6.2 ± 3.7 ng/mL vs. high GI 
5.0 ± 2.6 ng/mL, p = 0.02) (Table 4). Testosterone increased significantly from 0 to 8 wk on the high 
GI diet and increased non-significantly on the low GI diet, but there was no effect of diet composition 
(low GI 3.4 ± 1.8 nmol/L vs. high GI 5.0 ± 1.7 nmol/L, p = 0.50). 
Change in acne severity was not correlated with change in HOMA-IR or change in insulin (Pearson 
correlation r = −0.196, p = 0.244 and Pearson correlation r = −0.202, p = 0.225, respectively).  
In the present study we found no effect of GI on facial acne severity over 8 wk and no correlation 
between changes in acne severity and insulin concentrations or sensitivity. However, our hypothesis 
that a low GI diet would improve facial acne to a greater extent than a high GI diet was consistent with 
the finding that acne severity decreased more on the low GI diet (26%, p = 0.0004) compared with 
the high GI diet (16%, p = 0.01). Because the trial duration was dictated by the school term, our study 
was shorter than the ideal and usual intervention period of 12 wk in acne treatment studies [2,17].  
Figure 1. Change in facial acne severity from week 0 to week 8. Facial acne severity 
decreased more on the low glycemic index (GI) diet, but the difference between diets did 
not reach significance (acne score change: low GI mean ± SEM, n = 23, −0.65 ± 0.14 vs. 
high GI mean ± SEM, n = 20, −0.35 ± 0.15, p = 0.15).  




Table 3. Change in acne severity from week 0 to week 8 adjusted for differences in 
dermatologist, grading method and baseline 
1. 
 Diet    Mean   SEM  p 
2  Covariate and (p value) 
3 
Facial acne 
4  Low GI  −0.65  0.14  0.15   
  High GI  −0.35  0.15     
Facial acne 
5  Low GI  −0.61  0.13  0.28  −0.42 (0.004) 
  High GI  −0.40  0.14     
GI: glycemic index; 
1 Low GI diet, n = 23, high GI diet, n = 20; 
2 p value between groups (adjusted 
for differences in change in dermatologist and photo/in person acne grading method, but not 
adjusted for differences in baseline); 
3 Coefficient of covariate (p value) for results that have been 
adjusted for differences in baseline; 
4 Change in acne severity mean values adjusted for differences 
in change in dermatologist and photo/in person acne grading method, but not adjusted for 
differences in baseline; 
5 Change in acne severity mean values adjusted for differences in change in 
dermatologist and photo/in person acne grading method and adjusted for differences in baseline. 
Table 4. Change in blood parameters from week 0 to week 8 
1. 
  Diet   Mean  SEM  p 
2 p 
3 
Glucose (mmol/L)  Low GI  −0.1  0.1  0.58  0.74 
  High GI  −0.1  0.1  0.32   
Insulin (pmol/L)  Low GI  5.5  3.0  0.09  0.49 
  High GI  2.3  3.2  0.27   
HOMA-IR  Low GI  0.2  0.1  0.10  0.60 
  High GI  0.1  0.1  0.39   
Testosterone (nmol/L)  Low GI  3.4  1.8  0.07  0.50 
  High GI  5.0  1.7  0.03   
SHBG (nmol/L)  Low GI  0.4  1.2  0.71  0.75 
  High GI  −0.1  1.0  0.81   
FAI (nmol/L)  Low GI  14.4  10.3  0.17  0.92 
  High GI  11.4  7.9  0.16   
DHEA-S (µmol/L)  Low GI  0.2  0.2  0.35  0.86 
  High GI  0.3  0.2  0.17   
IGF-1 (nmol/L)  Low GI  1.8  1.9  0.35  0.10 
  High GI  1.9  2.4  0.43   
IGFBP-1 (ng/mL)  Low GI  −6.2  3.7  0.11  0.02 
  High GI  4.0  2.6  0.14   
IGFBP-3 (µg/mL)  Low GI  −0.3  0.4  0.46  0.86 
  High GI  −0.1  0.2  0.58   
DHEA-S: dehydroepiandrosterone-sulfate; FAI: free androgen index; GI: glycemic index; 
HOMA-IR: homeostasis modeling assessment of insulin resistance; IGF-1: insulin-like growth 
factor-1; IGFBP-1 and -3: insulin like growth factor binding proteins -1 and -3; SHBG: sex 
hormone binding globulin; 
1 Low GI diet, n = 19, high GI diet, n = 19 (5 subjects, 4 in low GI diet 
and 1 in high GI diet, did not provide blood samples); 
2 p valuewithin groups from 0 to 8weeks;  




The mean change in acne severity on the low GI diet was a decrease of over half a point out of 
three, which represents a change that is likely to be highly significant to subjects [18]. More sensitive 
and objective dermatological assessment tools may have highlighted differences to a greater extent.  
Improvements in acne on both the low and the high GI diet occurred despite the concurrent increase 
in testosterone levels, which reached significance on the high GI diet. Androgen levels increase during 
adolescence, hence higher testosterone may reflect a period of rapid sexual maturation [9,19]. In 
practice, androgen concentrations have been directly correlated to the severity of acne [20,21], thus the 
increases in testosterone might be expected to increase acne severity. 
The findings of the present study contrast with those of Smith et al. [2]. Those investigators 
managed a 13 point difference in GI (43 vs. 56), and GI values were lower in both groups, whereas the 
current study produced a 10 point difference in GI (51 vs. 61). However, differences in GL were 
similar because we had slightly lower intakes of carbohydrate (Smith et al. [2] 101 vs. 174; current 
102 vs. 157). Saturated fat was significantly different between interventions in both studies, which 
could have affected results because dietary fats can directly enter the pilosebaceous unit from the 
blood  [22]. Recent evidence suggests that an increased proportion of saturated fatty acids in skin 
surface triglycerides may decrease abnormal skin cell replication and improve acne [23,24]. 
Overall, our findings imply that low GI carbohydrates were not responsible for the improvements in 
facial acne reported by Smith et al. [2]. The increased weight loss on the low GL arm of that study 
(nearly 3 kg compared to the weight gain of 0.5 kg in the control group) suggests negative energy 
balance and could explain the declines in fasting insulin and HOMA-IR. The higher protein content 
and higher fiber of their low GL diet may have contributed to increased satiety and reduced food 
intake [25,26]. Energy restriction and weight loss per se are recognized to improve fasting insulin 
concentration and HOMA-IR, independent of diet composition. Even in the absence of weight loss, 
higher protein or fiber intake may lead to improvements in glucose and insulin metabolism [27,28]. 
SHBG production also increases after weight loss, implying decreased androgenic activity [8]. Indeed, 
when Smith et al. adjusted for change in BMI, the differences in total inflammatory plus   
non-inflammatory acne lesion counts, HOMA-IR, SHBG and FAI between diets were no longer 
significant (although IGFBP-1 and inflammatory lesion counts remained significant) [2]. 
We found a significant effect of diet on IGFBP-1 but not IGFBP-3 or IGF-1. However, unlike 
Smith et al., IGFBP-1 decreased on the low GI diet [2].In an acute study in lean, young healthy 
subjects, Brand-Miller et al. observed that serum IGFBP-1 declined acutely after both high and low GI 
meals; the mean change at 4 h being significantly more prolonged after the low GI meal [29]. This is 
consistent with the decrease in IGFBP-1 in the present study. Considering the improvement in acne 
within both diets, we might have expected IGFBP-1 to increase on both diets and IGF-1 to 
decrease [10,21]. It is possible that blood levels of IGF-1 do not directly reflect levels in cells and 
tissues and that the complexity of IGF and IGFBP interactions and dietary effects on the system makes 
interpretation difficult. 
Unlike Smith et al., we failed to see changes in SHBG or DHEA-S [2]. Improvements in acne 
severity might be expected to correspond to an increase in SHBG [30] and a fall in DHEA-S [21,31]. 
In postmenopausal women with hyperandrogenism, a low GI diet was able to increase SHBG and 
decrease testosterone concentration, although the study duration was longer [32]. Some studies have 




measurement of testosterone is prone to error. It is removed quickly from the circulation by the liver 
and target tissues, and may be produced locally in the pilosebaceous intracrine system [20]. 
The limitations of our study should be noted. Twelve subjects discontinued the study and three 
subjects were not available for the final acne gradings, representing a substantial drop out rate (26%). 
The 4-point acne grading method was novel and hence not internationally validated and capable of 
detecting only relatively large changes in the severity of inflammatory lesions (a change of one grade 
or more, e.g., from severe to moderate acne). Less obvious changes in inflammatory and 
non-inflammatory lesions may have been overlooked. Assessing acne severity at four weeks would 
have increased the scope of the study, but this was not possible due to commitments of the 
dermatologist. Studying adolescents at boarding school may prevent generalization of results to wider 
non-boarding adolescent population. The non-randomized alternate allocation study design may have 
resulted in selection bias. A control group (who were not given any dietary advice) would have been 
useful to determine the true significance of within-diet changes. The subjects were not blinded to the 
purpose of the study and food intake may have been under- or over-reported. Changes in insulin 
sensitivity may have occurred but gone undetected because HOMA-IR is a comparatively “blunt” 
measure of insulin sensitivity, reflecting hepatic rather than peripheral glucose metabolism. Food 
intake was not measured at baseline, so differences between habitual diet and intervention diets could 
not be assessed. Food diaries were only completed on weekends because it was felt that asking the 
students to record their food intake in such detail for a longer period would be too onerous, which 
meant that any differences between week day and weekend food intakes would have been missed 
(although the vast majority of students remained at school on weekends and hence week day diet 
would be similar to weekend diet). Validation of the food diaries (e.g., via weighed food records) may 
have increased the accuracy of the intake data. Finally, the difference in GI between diets may not 
have been large enough to materially affect postprandial glycemic and insulin responses in adolescent 
males. Larger differences (ranging from 13 to 28 units) were employed to effect changes in glycated 
proteins in diabetic subjects [33]. The GI of our high GI intervention may have been similar to 
habitual intake.  
A myriad of emotional and physiologic factors affect the pathogenesis of acne, making dietary 
studies in this area especially difficult, including stress [34,35] and nutrients other than carbohydrates 
(saturated fats [22,24], n-3 vs. n-6LCPUFA [36-39], vitamin D [40] and dairy [41]). n-3LCPUFA are 
increasingly recognized as anti-inflammatory agents [36], while n-6 fats are precursors of highly active 
mediators of inflammation [37]. n-3LCPUFA have been shown to increase IGFBP-3 in animals [38] 
and decrease IGF-1 in humans [39]. In this study, we found no difference in LCPUFA between diets, 
but did not differentiate between n-3 and n-6 isoforms. 
4. Conclusions 
This study suggests that a low GI diet does not significantly improve facial acne more than a 
macronutrient-matched high GI diet, although there was a trend for the low GI diet to improve acne to 
a greater extent than the high GI diet. However, the limitations of the study limit the conclusions that 
can be made from the results. The lack of a difference between diets may be due to short study 




previous study investigating dietary GI/GL may be explained by weight loss or differences in protein 
and/or fiber content. Future studies should employ randomized designs of at least 12 wk duration, 
subjects within a narrow age range, and using validated acne scoring systems [17]. Tight control of 
confounding factors, including weight, type and amount of fat, protein and carbohydrate, level of 
stress, and other limitations discussed above, is necessary. 
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